MedTrace Logo

Falcon Real World Evidence Registry

NCT06589310 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2026-05-22

No results posted yet for this study

Summary

This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.

Conditions

Interventions

DEVICE

Exact Sciences Multicancer Early Detection (MCED) Test

Exact Sciences MCED test, is a qualitative in vitro diagnostic (IVD) for the detection of alterations in circulating tumor DNA and tumor-associated protein levels, which are commonly associated with cancer. It is performed on plasma derived from peripheral blood specimens.

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Principal Investigators

  • Tomasz M Beer, MD · Exact Sciences

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2030-08-31
Completion
2031-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06589310 on ClinicalTrials.gov